Physician profile
Alfred Menard
NPI 1598797102
$1,842.14
in general payments reported to CMS, 2019-2025
8 companies · $71.05 in 2025
The $71.05 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.39 · 2022: $242 · 2023: $183 · 2024: $1,301 · 2025: $71.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $876 · Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $876.18 |
| Food and Beverage | $678.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,085.65 | 2024 | Sternalock Blu System, Sternalock 360 System, Advantagerib |
| Abiomed | $265.93 | 2021-2024 | Impella |
| Terumo Cardiovascular Systems Corporation | $168.43 | 2022 | |
| Baxter Healthcare | $143.81 | 2023 | Floseal |
| Saphena Medical, INC. | $74.00 | 2022 | |
| Ethicon US, LLC | $37.99 | 2025 | Ethicon |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.27 | 2021 | |
| Edwards Lifesciences Corporation | $33.06 | 2025 | Sapien 3 Ultra Resilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfred Menard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.